3CLpro

    3CLpro

      • Oncology Oncology

        Our oncology pipeline is grounded in a deep understanding of tumor biology and drug resistance mechanisms, combined with a sustained pursuit of​ innovative drug design strategies.

      • Infectious diseases Infectious diseases

        Our infectious disease pipeline is dedicated to developing broad-spectrum, small-molecule antiviral drugs. Target indications include epidemic diseases such as coronavirus disease 2019 (COVID-19), severe acute respiratory syndrome (SARS), and Middle East respiratory syndrome (MERS).

      在研管线列表
      Drug Candidate
      Therapeutic Area
      Target
      Drug Discovery
      Drug Optimization
      Preclinical
      Phase I
      Phase II
      Phase III
      Approved